Mixed beam radiotherapy and combination chemotherapy in localized pancreatic adenocarcinoma - preliminary results
Journal Article
·
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
A pilot study of mixed beam radiotherapy (fast neutrons alternating with photons) followed by combination chemotherapy with SMF (streptozotocin, 5-flouoruracil, mitomycin C) in localized pancreatic cancer was performed. Thirteen patients were treated and a median survival of 10.0 months was noted (range 5-30+). Toxicity was mild to moderate. Further studies of radiation and chemotherapy are indicated.
- Research Organization:
- Cleveland Clinic Foundation, OH
- OSTI ID:
- 7069305
- Journal Information:
- Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 8:7
- Country of Publication:
- United States
- Language:
- English
Similar Records
Gemcitabine Chemotherapy and Single-Fraction Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
3D Radiotherapy Can Be Safely Combined With Sandwich Systemic Gemcitabine Chemotherapy in the Management of Pancreatic Cancer: Factors Influencing Outcome
Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer
Journal Article
·
Sat Nov 01 00:00:00 EDT 2008
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:7069305
+9 more
3D Radiotherapy Can Be Safely Combined With Sandwich Systemic Gemcitabine Chemotherapy in the Management of Pancreatic Cancer: Factors Influencing Outcome
Journal Article
·
Tue Apr 01 00:00:00 EDT 2008
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:7069305
+11 more
Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer
Journal Article
·
Fri Dec 01 00:00:00 EST 2006
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:7069305
+13 more
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
CARCINOMAS
CHEMOTHERAPY
RADIOTHERAPY
SIDE EFFECTS
BIOLOGICAL RADIATION EFFECTS
FAST NEUTRONS
FLUOROURACILS
MEV RANGE 01-10
MITOMYCIN
PANCREAS
PATIENTS
PHOTONS
STREPTOZOCIN
SURVIVAL CURVES
TOXICITY
ANTI-INFECTIVE AGENTS
ANTIBIOTICS
ANTIMETABOLITES
ANTIMITOTIC DRUGS
ANTINEOPLASTIC DRUGS
AZINES
BARYONS
BIOLOGICAL EFFECTS
BODY
DIGESTIVE SYSTEM
DISEASES
DRUGS
ELEMENTARY PARTICLES
ENDOCRINE GLANDS
ENERGY RANGE
FERMIONS
GLANDS
HADRONS
HETEROCYCLIC COMPOUNDS
HYDROXY COMPOUNDS
MASSLESS PARTICLES
MEDICINE
MEV RANGE
NEOPLASMS
NEUTRONS
NUCLEAR MEDICINE
NUCLEONS
ORGANIC COMPOUNDS
ORGANIC FLUORINE COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
PYRIMIDINES
RADIATION EFFECTS
RADIOLOGY
THERAPY
URACILS
550603* - Medicine- External Radiation in Therapy- (1980-)
560151 - Radiation Effects on Animals- Man
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
CARCINOMAS
CHEMOTHERAPY
RADIOTHERAPY
SIDE EFFECTS
BIOLOGICAL RADIATION EFFECTS
FAST NEUTRONS
FLUOROURACILS
MEV RANGE 01-10
MITOMYCIN
PANCREAS
PATIENTS
PHOTONS
STREPTOZOCIN
SURVIVAL CURVES
TOXICITY
ANTI-INFECTIVE AGENTS
ANTIBIOTICS
ANTIMETABOLITES
ANTIMITOTIC DRUGS
ANTINEOPLASTIC DRUGS
AZINES
BARYONS
BIOLOGICAL EFFECTS
BODY
DIGESTIVE SYSTEM
DISEASES
DRUGS
ELEMENTARY PARTICLES
ENDOCRINE GLANDS
ENERGY RANGE
FERMIONS
GLANDS
HADRONS
HETEROCYCLIC COMPOUNDS
HYDROXY COMPOUNDS
MASSLESS PARTICLES
MEDICINE
MEV RANGE
NEOPLASMS
NEUTRONS
NUCLEAR MEDICINE
NUCLEONS
ORGANIC COMPOUNDS
ORGANIC FLUORINE COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
PYRIMIDINES
RADIATION EFFECTS
RADIOLOGY
THERAPY
URACILS
550603* - Medicine- External Radiation in Therapy- (1980-)
560151 - Radiation Effects on Animals- Man